The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

Upcoming Meetings

  new dateESFH 21st  Congress (Virtual)
              2021,  May 26th - 27th

                          PROGRAM

Details and Registration https://www.esfh2020.com/                            

Poster webinar 4 2021     World Apheresis Association  (WAA) 
         & Hematological  Raare Diseases Society,
             is pleased to announce the upcoming
     virtual webinar on April 28, 2021
                              Apheresis in SARS- CoV-2 Infection &
  Convalescent Plasma Donors During COVID-19 Pandemic

                                    Final Program 
                                                  
                               PROGRAM overview
                              

  Prof. Volker Witt is organizing an Academic Course for Techniques in Apheresis
at the University of Krems in Lower Austria.  Folder in German Language. Second course will be in English   

        

Important

Webinars produced  by Terumo BCT
with the collaboration of ESFH

Anticoagulation Management in Therapeutic Plasma Exchange
https://event.on24.com/wcc/r/1456764/D92CCED5B651D872414BAC48B2EC6CA0?partnerref=esfh 

Plasma Exchange: Multiple Venous Access Versus Peripheral Access?
http://event.on24.com/wcc/r/1394067/8ECB6E15DA4493C7768B1F97C4C80DCE?partnerref=esfh

What Technology Would You Use for Plasma Exchange?
http://event.on24.com/wcc/r/1343905/42FD04644AC1D9827165929D80BBA131?partnerref=esfh

Advancing Apheresis in Neurology: Review of Neurological Disease Indications for Plasma Exchange
https://event.on24.com/wcc/r/1456776/073F252EFC9FDEC2B81253C9FF382769?partnerref=esfh

Previous ESFH Congress  ESFH 20th Congress  2018
13th/14th June 2018
Hospital La Fe, Valencia, Spain

Characterization of buffy coat-derived granulocytes for clinical use: a...

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...

Mobilization of Hematopoietic Progenitor Cells from Allogeneic Healthy...

In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...

Adverse events in apheresis: An update of the WAA registry data

In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...